Global Veterinary Drug Market Growth 2023-2029

Global Veterinary Drug Market Growth 2023-2029

Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.
LPI (LP Information)' newest research report, the “Veterinary Drug Industry Forecast” looks at past sales and reviews total world Veterinary Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Veterinary Drug sales for 2023 through 2029. With Veterinary Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Drug industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Veterinary Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Drug.
The global Veterinary Drug market size is projected to grow from US$ 23200 million in 2022 to US$ 34220 million in 2029; it is expected to grow at a CAGR of 34220 from 2023 to 2029.
The key players of Veterinary Drug include Zoetis, Elanco, Boehringer Ingelheim, Merck, etc. The top four players of Veterinary Drug account for approximately 56% of the total market. Asia-Pacific is the largest market of Veterinary Drug accounting for about 34%, followed by Europe and North America. In terms of Type, Parasiticides is the largest segment, with a share about 28%. And in terms of Application, the largest application is Pets, followed by Cattle.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Drug market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Anti-Infectives
Anti-Inflammatory
Parasiticides
Analgesics
Sedatives
Others
Segmentation by application
Pets
Cattle
Poultry
Swine
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Zoetis
Elanco
Boehringer Ingelheim
Merck
Virbac
Ceva
Vetoquinol
Dechra
Norbrook
Phibro
Huvepharma
Hipra
Ouro Fino Saude
CAHIC
Orion
Ringpu Biology
Nippon Zenyaku Kogyo
Farmavet-Pasteur

Key Questions Addressed in this Report
What is the 10-year outlook for the global Veterinary Drug market?
What factors are driving Veterinary Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Drug market opportunities vary by end market size?
How does Veterinary Drug break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.